# EUSA Pharma: Pharmaceuticals, Hemel Hempstead, United Kingdom

> EUSA Pharma: EUSA Pharma is a pharmaceutical company developing and licensing late-stage oncology, pain control, and critical care products.

Source: https://millionrounds.com/startup/eusa-pharma (Millionrounds; every figure on the page links to its filing or article)

United Kingdom · [Pharmaceuticals startup](https://millionrounds.com/companies)

# EUSA Pharma

EUSA Pharma is a pharmaceutical company developing and licensing late-stage oncology, pain control, and critical care products.

Funding reported Last round: Undisclosed round

Pharmaceuticals Hemel Hempstead, United Kingdom

Company summary

- **Founded:** 2006 20 years old
- **Team:** 51 51 to 200 people
- **Funding reported:** 54.2M as listed, currency not stated
- **Last round:** Undisclosed round May 2009

How sure we are

- ✓ **Listed** We know it exists and what it does
- 2 **Funding reported** A company dataset reports a raise
- 3 **Observed** A filing or a dated announcement confirms a round

No round for EUSA Pharma has been confirmed by a filing or an announcement yet, so nothing here counts toward an investor's record. [How we decide](https://millionrounds.com/methodology)

## What company datasets say EUSA Pharma raised

Funding, as reported

Reported in all **54.2M** in the source's currency

Rounds **7**

Last round **Undisclosed round**

Last round date **May 2009**

Investors listed **25**

## Founders and team

From EUSA Pharma's own website: 12 on the team.

- **Robert Koremans** Chief Executive Officer
- **Alessandra Abate** Group Chief People and Culture Officer
- **Bibianne Bon** Group Chief Legal Officer
- **Lucia Abbatantuoni** Chief of Staff
- **Mike McClellan** Chief Financial Officer
- **Alberto Martinez** Executive VP Specialty & Primary Care Business Unit
- **Alessandro Gilio** Executive VP Group Industrial Operations
- **Gabriele Finzi** Executive VP Corporate Development & Licensing
- **Scott Pescatore** Executive VP Rare Diseases Business Unit
- **Laura Conti** Group Communications Director
- **Silvia Signoretti** Group Corporate Law Counsel and Secretary
- **Stefania Pesce** ESG Manager

## Exits

Exit

Exit Buyer Price When

Acquired [Jazz Pharmaceuticals](https://millionrounds.com/fund/jazz-pharmaceuticals) $650M Apr 2012

Acquired EUSA Pharma $23M Mar 2008

## Pharmaceuticals in United Kingdom

Startups like it

- [**Redx Pharma** Alderley Park · founded 2010](https://millionrounds.com/startup/redx-pharma)
- [**Archimedes Pharma** Reading · founded 2004](https://millionrounds.com/startup/archimedes-pharma)
- [**NextPharma** London · founded 2000](https://millionrounds.com/startup/nextpharma)
- [**Glide Pharmaceutical Technologies Limited** Abingdon · founded 2001](https://millionrounds.com/startup/glide-pharmaceutical-technologies-limited)
- [**Penn Pharma** Tredegar · founded 1979](https://millionrounds.com/startup/penn-pharma)
- [**Jhoots Pharmacy** Walsall · founded 2002](https://millionrounds.com/startup/jhoots-pharmacy)
- [**Envision Pharma Group** Global · founded 2001](https://millionrounds.com/startup/envision-pharma-group)
- [**ClinTec International** Glasgow · founded 1997](https://millionrounds.com/startup/clintec-international)

## Is this your company?

Add your raise, your deck and your story, and put EUSA Pharma in front of investors. Or tell us what we have wrong.

[List your startup](https://millionrounds.com/list-your-startup)[Send a correction](https://millionrounds.com/corrections)